Product NDC: | 63323-307 |
Proprietary Name: | Tobramycin |
Non Proprietary Name: | TOBRAMYCIN SULFATE |
Active Ingredient(s): | 40 mg/mL & nbsp; TOBRAMYCIN SULFATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-307 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065120 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041130 |
Package NDC: | 63323-307-51 |
Package Description: | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
NDC Code | 63323-307-51 |
Proprietary Name | Tobramycin |
Package Description | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Product NDC | 63323-307 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TOBRAMYCIN SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20041130 |
Marketing Category Name | ANDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | TOBRAMYCIN SULFATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |